Commerzbank AG upgraded QIAGEN (ETR:QIA) to Buy in a report released today.
- Updated: September 16, 2016
Commerzbank AG has upgraded QIAGEN(ETR:QIA) to Buy in a statement released on 9/17/2016.
Only yesterday QIAGEN (ETR:QIA) traded 0.00% even at 23.64EUR. The company’s 50-day average is 0.00EUR and its two hundred day moving average is 0.00EUR. The last stock close is up 0.00% from the 200-day moving average, compared with the S&P 500 Index which has fallen -0.01% over the same period. Trading volume was held steady, with 0 shares of QIA changing hands on par with the typical 0 shares..
See Graph Below:
QIAGEN has a one-year low of 0.00EUR and a 52 week high of 0.00EUR. The company’s total market value is currently 0.0 EUR.
Brief Synopsis On QIAGEN (ETR:QIA)
QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to decide on further action. It offers solutions in molecular diagnostics, applied testing, and pharma and academia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.